Clinical Trials Browser

Neoplasm Metastasis × darolutamide × 1 year × Clear all

Urogenital Diseases, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT06660862 2026-01-08

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Phase 4 Not yet recruiting

80 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Clinical Trials

STRIKE-001

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.